For example, systemic injections of IGF-1 mimicked some of the effects of exercise in the brain [68], and genetically reduced IGF-1 signaling in the whole organism reduced inflammation and neuronal loss in a mouse Alzheimer disease model [32]. The gene discussed is IGF1; the disease is early-onset autosomal dominant Alzheimer disease.